February 24, 2023 | By John Raslavsky | Liver, NASH | Blog, Clinical trials, Fatty Liver Disease, Fibroscan, Liver disease, liver health
Obesity has become one of the most common and serious public health issues in recent years, leading to many health problems. Yet, many remain unaware of the consequences of obesity on the liver. Learn more in our blog below! Excess …
December 9, 2022 | By John Raslavsky | Effects of HIV on the Liver, Liver | AIDS, Blog, Clinical research, Fatty Liver Disease, Fibroscan, HIV, Liver disease, liver health
December is National HIV/AIDS Awareness Month, and many people are unaware of the significant impact this virus can have on the liver. HIV is one of the leading causes of cirrhosis and NASH in the United States. Let’s take a …
July 22, 2022 | By John Raslavsky | Clinical Research, Hepatitis | Clinical trials, Hepatitis in Children, Hepatitis Outbreak, Liver disease
The Sudden Wave of Hepatitis Amongst Children A recent upsurge in hepatitis cases involving children has caused alarm nationwide. Let’s dive into why this age group is suddenly experiencing a spike in occurrences. An Origin Story – How Cases of …
December 15, 2020 | By John Raslavsky | Cirrhosis, Clinical Trials | Blog, Clinical research, Fatty Liver Disease, Liver disease
Cirrhosis is the replacement of healthy liver tissue with non-living scar tissue. It is a complication of liver disease from the progressive damage caused if not treated. Most people have no symptoms in the early stages, where the progression …